Animal studies may provide a clue as to whether R-(−)-apomorphine can be used to neutralize hyperphosphorylated tau following brain injury or general anesthesia exposure, thus reducing the likelihood of AD and ADRD after recovery. The gene discussed is MAPT; the disease is Alzheimer disease.